Skip to content
AnalystLens

CARDINAL HEALTH INC 8-K Report, Material Agreement (Oct 10, 2025)

Reports
Material Agreements·Exhibits & Filings
Filing Date
Filed October 10, 2025
Period End
October 7, 2025
Security
CAH
In the record · 2016–202610-K1110-Q328-K120

CAH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Oct ’17Oct ’17
  2. Leadership change8-K · Aug ’20Aug ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed October 10, 2025. Cited figures are marked; the original filing is the authoritative source.

Cardinal Health, Inc. (CAH) has entered into a new 364-Day Credit Agreement, effective October 7, 2025, replacing its prior agreement.

This new facility provides the company with access to $1.0 billiona in revolving credit, extending through October 6, 2026. This ensures continued financial flexibility for general corporate purposes and supports its commercial paper program. A key feature allows for the potential conversion of outstanding loans into non-revolving term loans, payable one year after the agreement's termination date, offering further flexibility in managing its debt obligations.

Key Highlights

  1. Secured $1.0 billion in revolving credit under a new 364-Day Credit Agreement.
  2. The credit facility extends through October 6, 2026.
  3. The agreement allows for conversion of outstanding loans to term loans, repayable one year post-termination.
  4. Maintains a financial covenant requiring a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00.
  5. The credit facility will be used for general corporate purposes and backs the company's commercial paper program.
  6. The new agreement replaces the previous 364-Day Credit Agreement that expired.

Frequently Asked Questions

  1. What is the principal purpose of the new 364-Day Credit Agreement?

    The new 364-Day Credit Agreement provides Cardinal Health with continued access to $1.0 billion in revolving credit, which will be used for general corporate purposes and to support the company's commercial paper program. This ensures ongoing financial liquidity and flexibility.

  2. When does the new credit facility expire, and what options are available at expiration?

    The credit facility expires on October 6, 2026. The company has the option, subject to certain conditions, to convert any outstanding loan principal into non-revolving term loans that would be repaid in full one year after the termination date.

  3. What is the key financial covenant in the new agreement?

    The primary financial covenant requires Cardinal Health to maintain a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00, as of the last day of any fiscal quarter. This covenant is crucial for demonstrating the company's ability to manage its debt relative to its earnings.

  4. Does this new agreement indicate any immediate financial distress for Cardinal Health?

    No, this filing indicates proactive financial management. Entering into a new credit agreement, especially a revolving facility, is a standard practice for companies to ensure access to capital for ongoing operations and strategic initiatives, and does not suggest immediate distress.